214 related articles for article (PubMed ID: 25268699)
1. Doxycycline inhibits inflammation-induced lymphangiogenesis in mouse cornea by multiple mechanisms.
Han L; Su W; Huang J; Zhou J; Qiu S; Liang D
PLoS One; 2014; 9(9):e108931. PubMed ID: 25268699
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-33 promotes inflammation-induced lymphangiogenesis via ST2/TRAF6-mediated Akt/eNOS/NO signalling pathway.
Han L; Zhang M; Liang X; Jia X; Jia J; Zhao M; Fan Y
Sci Rep; 2017 Sep; 7(1):10602. PubMed ID: 28878285
[TBL] [Abstract][Full Text] [Related]
3. High Mobility Group Box-1 Promotes Inflammation-Induced Lymphangiogenesis via Toll-Like Receptor 4-Dependent Signalling Pathway.
Han L; Zhang M; Wang M; Jia J; Zhao M; Fan Y; Li X
PLoS One; 2016; 11(4):e0154187. PubMed ID: 27100831
[TBL] [Abstract][Full Text] [Related]
4. Qingjie Fuzheng Granule suppresses lymphangiogenesis in colorectal cancer via the VEGF-C/VEGFR-3 dependent PI3K/AKT pathway.
Huang B; Lu Y; Gui M; Guan J; Lin M; Zhao J; Mao Q; Lin J
Biomed Pharmacother; 2021 May; 137():111331. PubMed ID: 33578235
[TBL] [Abstract][Full Text] [Related]
5. Endothelial nitric oxide synthase mediates lymphangiogenesis and lymphatic metastasis.
Lahdenranta J; Hagendoorn J; Padera TP; Hoshida T; Nelson G; Kashiwagi S; Jain RK; Fukumura D
Cancer Res; 2009 Apr; 69(7):2801-8. PubMed ID: 19318557
[TBL] [Abstract][Full Text] [Related]
6. Role of macrophages in inflammatory lymphangiogenesis: Enhanced production of vascular endothelial growth factor C and D through NF-kappaB activation.
Watari K; Nakao S; Fotovati A; Basaki Y; Hosoi F; Bereczky B; Higuchi R; Miyamoto T; Kuwano M; Ono M
Biochem Biophys Res Commun; 2008 Dec; 377(3):826-31. PubMed ID: 18951870
[TBL] [Abstract][Full Text] [Related]
7. Hydroxysafflor yellow A regulates lymphangiogenesis and inflammation via the inhibition of PI3K on regulating AKT/mTOR and NF-κB pathway in macrophages to reduce atherosclerosis in ApoE-/- mice.
Feng X; Du M; Li S; Zhang Y; Ding J; Wang J; Wang Y; Liu P
Phytomedicine; 2023 Apr; 112():154684. PubMed ID: 36738477
[TBL] [Abstract][Full Text] [Related]
8. Low-dose cadmium induces lymphangiogenesis through activation of the STAT3 signaling pathway.
Xing Y; Wang X; Liu J; Zhang Y; Tianran H; Dong L; Tian J; Liu J
Biomed Pharmacother; 2024 Jun; 175():116741. PubMed ID: 38744218
[TBL] [Abstract][Full Text] [Related]
9. Slit2N and Robo4 regulate lymphangiogenesis through the VEGF-C/VEGFR-3 pathway.
Yu J; Zhang X; Kuzontkoski PM; Jiang S; Zhu W; Li DY; Groopman JE
Cell Commun Signal; 2014 Apr; 12():25. PubMed ID: 24708522
[TBL] [Abstract][Full Text] [Related]
10. Novel application assigned to toluquinol: inhibition of lymphangiogenesis by interfering with VEGF-C/VEGFR-3 signalling pathway.
García-Caballero M; Blacher S; Paupert J; Quesada AR; Medina MA; Noël A
Br J Pharmacol; 2016 Jun; 173(12):1966-87. PubMed ID: 27018653
[TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide increases the release of VEGF-C that enhances cell motility and promotes lymphangiogenesis and lymphatic metastasis through the TLR4- NF-κB/JNK pathways in colorectal cancer.
Zhu G; Huang Q; Huang Y; Zheng W; Hua J; Yang S; Zhuang J; Wang J; Ye J
Oncotarget; 2016 Nov; 7(45):73711-73724. PubMed ID: 27713159
[TBL] [Abstract][Full Text] [Related]
12. Foretinib inhibits angiogenesis, lymphangiogenesis and tumor growth of pancreatic cancer in vivo by decreasing VEGFR-2/3 and TIE-2 signaling.
Chen HM; Tsai CH; Hung WC
Oncotarget; 2015 Jun; 6(17):14940-52. PubMed ID: 25909285
[TBL] [Abstract][Full Text] [Related]
13. Suppression of lymphangiogenesis by soluble vascular endothelial growth factor receptor-2 in a mouse lung cancer model.
Maehana S; Nakamura M; Ogawa F; Imai R; Murakami R; Kojima F; Majima M; Kitasato H
Biomed Pharmacother; 2016 Dec; 84():660-665. PubMed ID: 27697638
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor receptor-3 directly interacts with phosphatidylinositol 3-kinase to regulate lymphangiogenesis.
Coso S; Zeng Y; Opeskin K; Williams ED
PLoS One; 2012; 7(6):e39558. PubMed ID: 22745786
[TBL] [Abstract][Full Text] [Related]
15. Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3.
Kodera Y; Katanasaka Y; Kitamura Y; Tsuda H; Nishio K; Tamura T; Koizumi F
Breast Cancer Res; 2011 Jun; 13(3):R66. PubMed ID: 21693010
[TBL] [Abstract][Full Text] [Related]
16. MT1-MMP sheds LYVE-1 on lymphatic endothelial cells and suppresses VEGF-C production to inhibit lymphangiogenesis.
Wong HL; Jin G; Cao R; Zhang S; Cao Y; Zhou Z
Nat Commun; 2016 Mar; 7():10824. PubMed ID: 26926389
[TBL] [Abstract][Full Text] [Related]
17. Soluble vascular endothelial growth factor receptor 3 is essential for corneal alymphaticity.
Singh N; Tiem M; Watkins R; Cho YK; Wang Y; Olsen T; Uehara H; Mamalis C; Luo L; Oakey Z; Ambati BK
Blood; 2013 May; 121(20):4242-9. PubMed ID: 23476047
[TBL] [Abstract][Full Text] [Related]
18. Doxycycline-mediated inhibition of corneal angiogenesis: an MMP-independent mechanism.
Su W; Li Z; Li F; Chen X; Wan Q; Liang D
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):783-8. PubMed ID: 23249709
[TBL] [Abstract][Full Text] [Related]
19. TGFBIp mediates lymphatic sprouting in corneal lymphangiogenesis.
Lin T; Zhang X; Lu Y; Gong L
J Cell Mol Med; 2019 Nov; 23(11):7602-7616. PubMed ID: 31456353
[TBL] [Abstract][Full Text] [Related]
20. The effect of podoplanin inhibition on lymphangiogenesis under pathological conditions.
Maruyama Y; Maruyama K; Kato Y; Kajiya K; Moritoh S; Yamamoto K; Matsumoto Y; Sawane M; Kerjaschki D; Nakazawa T; Kinoshita S
Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):4813-22. PubMed ID: 24985477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
